Redcliffe Labs ropes in Ishaan Khanna as Director - Reproductive Medicine and Genetics

Published On 2022-05-27 04:30 GMT   |   Update On 2022-05-27 12:01 GMT

New Delhi: Redcliffe Labs, a unit of Redcliffe Lifetech in the U.S. and India, has recently announced Ishaan Khanna as Director - Reproductive Medicine and Genetics.Ishaan is a techno-commercial leader with over 19 years of experience in institutional and commercial healthcare businesses. He started his career as scientist with assignments spanning across Australia and UK. After coming back...

Login or Register to read the full article

New Delhi: Redcliffe Labs, a unit of Redcliffe Lifetech in the U.S. and India, has recently announced Ishaan Khanna as Director - Reproductive Medicine and Genetics.

Ishaan is a techno-commercial leader with over 19 years of experience in institutional and commercial healthcare businesses.  He started his career as scientist with assignments spanning across Australia and UK. After coming back to India he worked in Business development leadership roles in Biotech and pharma companies such as Avesthagen and Krishna Antioxidants.
His last assignment was at Lifecell where he was the CEO, Biobank and Diagnostics where he spent over a decade. 
"He also brought some of the key diagnostic platforms to India for the first time such as QFPCR and rapid genetic testing to support the need of sick infants and pregnant women and building leadership in domains such as newborn screening. In his previous roles he has built pan India network of labs and efficient networks, something which he wishes to do at a much larger scale at Redcliffe, " the release stated.
Ishaan has been facilitated with various awards such as the Best Healthcare CEO, Sustainability leader and Start-up Baron. Ishaan is a Gold Medalist in Bachelors Biotechnology, Manipal University, Kasturba Medical College/ Manipal Lifescience School India; and holds Masters in Biotechnology and Masters in Enterprise, University of Manchester.
Dheeraj Jain, the Founder of Redcliffe Labs said, "Ishaan comes with a rich experience and his work reflects his interest in taking healthcare to the masses, which is exactly in sync with Redcliffe's philosophy. We are confident that he will perfectly lead this role. This appointment is also important as the Reproductive Medicine and Genetics market continues to grow and evolve, offering great opportunities for players like us in this space. As we continue to experience strong growth momentum, we feel having the right team is key."
"I am honoured to be associated with Redcliffe Labs at a time when the healthcare and genetics industry in India is witnessing upward growth. I am looking forward to be a part of Redcliffe team and its growth story," said the newly appointed Director - Reproductive Medicine and Genetics at Redcliffe Labs, Ishaan Khanna.

Read also: Ex Dr Reddys President Saumen Chakraborty joins Premas Biotech Board of Directors

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News